期刊文献+

原发性痛经与继发性痛经非手术识别方法探讨 被引量:11

Non-operative Identification of Primary and Secondary Dysmenorrhea
下载PDF
导出
摘要 目的探讨痛经患者的临床特征,为原发性痛经与继发性痛经的非手术识别方式提供参考。方法对336例痛经的临床特征进行分析,比较原发性痛经与继发性痛经患者的疼痛特点。结果原发性痛经80例,继发性痛经256例,初潮出现痛经的比例分别为25.0%(20/80)、30.1%(77/256),无统计学差异(χ2=0.765,P=0.382)。继发性痛经组患者疼痛VAS(7.9±1.8)分,显著高于原发性痛经组(7.4±1.8)分(t=-2.169,P=0.031),痛经加重的比例56.6%(145/256)显著高于原发性痛经组患者38.8%(31/80)(χ2=7.821,P=0.004)。继发性痛经组患者合并消化、泌尿系统伴随症状的比例为69.5%(178/256),显著高于原发性痛经组43.8%(35/80)(χ2=17.458,P=0.000),非甾体类抗炎药的疼痛缓解率为65.5%(78/119),显著低于原发性痛经组89.6%(26/29)(χ2=6.488,P=0.011)。结论原发性痛经与继发性痛经均可于初潮出现,痛经严重、疼痛持续加重、有伴随症状、非甾体类抗炎药治疗无效的患者,应注意继发性痛经的识别。 Objective To observe the clinical characteristics of patients with dysmenorrhea and to provide basis for nonoperative identification of primary and secondary dysmenorrhea. Methods The clinical features and pain characteristics of 336 patients with dysmenorrhea were analyzed. Results Eighty patients were diagnosed as having primary dysmenorrhea and 256 patients were diagnosed as having secondary dysmenorrhea. The dysmenorrhea at menarche occurred in 25. 0%( 20 /80) of primary and30. 1%( 77 /256) of secondary dysmenorrhea patients,with no significant differences( χ2= 0. 765,P = 0. 382). As compared with primary dysmenorrhea group,the secondary dysmenorrhea group showed more severe pain( 7. 9 ± 1. 8 vs. 7. 4 ± 1. 8,t =- 2. 169,P = 0. 031),higher percentages of aggravated dysmenorrhea [56. 6%( 145 /256) vs. 38. 8%( 31 /80),χ2= 7. 821,P = 0. 004 ],higher percentages of accompany symptoms [69. 5%( 178 /256) vs. 43. 8%( 35 /80),χ2= 17. 458,P = 0. 000 ],and lower relief rate to regular treatment [65. 5%( 78 /119) vs. 89. 6%( 26 /29),χ2= 6. 488,P = 0. 011 ],respectively. Conclusions Both primary and secondary dysmenorrhea could occur at menarche. Patients with severe and aggravated dysmenorrhea, accompany symptoms,and low routine medical treatment efficiency should be paid more attention of secondary dysmenorrhea.
出处 《中国微创外科杂志》 CSCD 北大核心 2015年第3期201-204,共4页 Chinese Journal of Minimally Invasive Surgery
关键词 痛经 子宫内膜异位症 子宫腺肌症 Dysmenorrhea Endometriosis Adenomyosis
  • 相关文献

参考文献22

  • 1Latthe P, Latthe M, Say L, et al. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health ,2006,6 (6) : 177 - 183.
  • 2Parker MA, Sneddon AE, Arbon P. The menstrual disorder of teenagers (MDOT) study: determining typical menstrual patterns and menstrual disturbance in a large populationbased study of Australian teenagers. BJOG ,2010,1179 (2) : 185 - 192.
  • 3丰有吉.妇产科学.北京:人民卫生出版社,2011.137.
  • 4王文莉,段华.子宫内膜异位症痛经机制的研究进展[J].中国微创外科杂志,2009,9(12):1100-1102. 被引量:16
  • 5Roman JD. Adolescent endometriosis in the Waikato region of New Zealand-a comparative cohort study with a mean follow-up time of 2. 6 years. Aust N Z J Obstet Gynaecol,2010,50(2) :179 - 183.
  • 6Unger CA, Laufer MR. Progression of endometriosis in non- medically managed adolescents: a case series. J Pediatr Adolesc Gynecol,2011,24 :e21 - e23.
  • 7The international pelvic pain society. Pelvic pain assessment form. http://www, pelvicpain, org/docs/resources/forms/History-and- Physical-Form -English. aspx, 2008,4.
  • 8冷金花,郎景和,李华军,刘珠凤,孙大为,朱兰,赵学英,李晓燕.子宫内膜异位症非手术诊断方法探讨[J].现代妇产科进展,2007,16(11):846-848. 被引量:39
  • 9Dunselman GA, Vermeulen N, Becker C. ESHRE guideline: management of women with endometriosis. Hum Reprod,2014,29 (3) :400 -412.
  • 10Treloar SA, Bell TA, Nagle CM, et al. Early menstrual characteristics associated with subsequent diagnosis of endometriosis. Am J Obstet Gyneeol,2010,202(6) :534. el -e6.

二级参考文献49

  • 1Bishop-Bailey D,Calatayud S,Warner TD,et al.Prostaglandins and the regulation of tumor growth.J Environ Pathol Toxicol Oncol,2002,21:93-101.
  • 2Brenner RM,Nayak NR,Slayden OD,et al.Premenstrual and menstrual changes in the macaque and human endometrium:relevance to endometriosis.Ann N Y Acad Sci,2002,955:60-74.
  • 3Bulun SE,Imir G,Utsunomiya H,et al.Aromatase in en.dometriosis and uterine leiomyomata.J Steroid Bio Chem Mol Biol,2005,95:57-62.
  • 4Attaran M,Falcone T,Goldbegr J.Endometriosis:still tough to diagnose and treat.Cleve Clin J Med,2002,69:647-653.
  • 5Kitawaki J.Adenomyosis:the pathophysiology of an oestrogen-dependent disease.Best Pract Res Clin Obstet Gynaecol,2006,20:493-502.
  • 6Siebel AL,Gehring HM,Parry LJ.Steroid-independent regulation ofuterine oxytocin receptor.J Neuroendocrinol,2004,16:398-402.
  • 7Ebert AD,Bartley J,David M,et al.Aromatase inhibitors-theoretical concept and present experiences in the treatment of endometriosis.Zentralbl Gynakol,2003,125:247-251.
  • 8Daguati R,Somigliana E,Vigano P,et al.Progestogens and estroprogestins in the treatment of pelvic pain associated with endometriosis.Minerva Ginecol,2006,58:499-510.
  • 9Richter ON,Tschubel K,Schmolling J.et al.Immunohistochemical reactivity of myometrial oxytocin receptor in extracorporeally perfused nonpregnant human uteri.Arch Gynecol Obstet,2003,269:16-24.
  • 10Mechsner S,Bartley J,Loddenkemper C,et al.Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts.Fertil Steril,2005,83(Suppl 1):S1220-S1231.

共引文献82

同被引文献96

引证文献11

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部